APA (7th ed.) Citation

Kosman, V. M., Karlina, M. V., Faustova, N. M., Ezhova, E. A., Kotelnikova, I. G., Makarov, V. G., & Makarova, M. N. (2023). Considerations for the Bioanalytical Part of Equivalence Studies of Biosimilar Nadroparin Calcium. Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’).

Chicago Style (17th ed.) Citation

Kosman, V. M., M. V. Karlina, N. M. Faustova, E. A. Ezhova, I. G. Kotelnikova, V. G. Makarov, and M. N. Makarova. Considerations for the Bioanalytical Part of Equivalence Studies of Biosimilar Nadroparin Calcium. Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’), 2023.

MLA (9th ed.) Citation

Kosman, V. M., et al. Considerations for the Bioanalytical Part of Equivalence Studies of Biosimilar Nadroparin Calcium. Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’), 2023.